Related Experiment Video

Updated: Aug 20, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

[Mevastatin induced apoptosis in U266 human myeloma cell line]

Judit Jánosi1, Anna Sebestyén, József Bocsi

  • 1Országos Gyógyintézeti Központ, Budapest 1135, Hungary. janosijudit@hotmail.com

Magyar Onkologia
|January 19, 2005
PubMed

Insights

Mevastatin, a statin, triggers apoptosis in human myeloma cells by affecting mitochondrial pathways and down-regulating BCL-2. This statin also stimulates syndecan-1 shedding, offering potential therapeutic insights.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Context:

  • Statins are cholesterol-lowering drugs with demonstrated in vitro anti-cancer properties.
  • Hypercholesterolemia treatment involves statins.
  • Tumor cell lines undergo apoptosis when treated with statins.

Purpose:

  • To investigate the effect of mevastatin on U266 human myeloma cells.
  • To analyze the mechanism of mevastatin-induced apoptosis in myeloma cells.

Summary:

  • Mevastatin, an HMG-COA reductase inhibitor, induced apoptosis in U266 human myeloma cells.
  • Apoptosis involved increased caspase activity, mitochondrial membrane depolarization, and down-regulation of BCL-2 mRNA and protein.
  • The mitochondrial pathway, supported by caspase-8 and cleaved BID, was implicated, independent of death-ligand/death-receptor pathways.
  • Mevastatin also promoted syndecan-1 shedding from myeloma cell surfaces.

Impact:

  • Mevastatin demonstrates potential as an anti-myeloma agent by inducing apoptosis through intrinsic mitochondrial pathways.
  • Understanding mevastatin's mechanism provides insights into novel therapeutic strategies for multiple myeloma.
  • The study highlights the role of the mevalonate pathway and syndecan-1 shedding in cancer cell apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.